Deciphering MMRN1 diagnostic and therapeutic implications in the substantia nigra of Parkinson’s disease patients via integrative bioinformatic analysis and multi-omics studies

Yu Ning, Wei Gao, Yan Gao · 2026

Read Deciphering MMRN1 diagnostic and therapeutic implications in the substantia nigra of Parkinson’s disease patients via integrative bioinformatic analysis and multi-omics studies by Yu Ning, Wei Gao, Yan Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13323139.txt.

Description

Yu Ning, Wei Gao and Yan Gao hunt for a new diagnostic and drug target in Parkinson's disease, in a 2026 multi-omics study of the substantia nigra. That brain region loses dopamine cells in Parkinson's, and current treatments remain limited for older patients.

Starting from public gene datasets, the team combined differential expression, network analysis and Mendelian randomisation to nominate risk genes tied to the disease. Three machine learning methods then picked a central factor, MMRN1, whose diagnostic strength was checked across several independent datasets. Single-cell data mapped its molecular and immune patterns, and network screening with docking searched for drugs that might act on it. The authors present MMRN1 as a candidate for testing.

Catalog record

CREATORYu Ning, Wei Gao, Yan Gao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29797
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13323139

Browse the full library · About the Tower of Babel